This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Nordion Launches A New And Improved TheraSphere® Website To Meet The Needs Of Liver Cancer Physicians, Patients And Caregivers Worldwide

Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services for the prevention, diagnosis and treatment of disease, announced today that it has launched a new and improved, intuitive, feature-rich TheraSphere® website, providing liver cancer patients and physicians with customized TheraSphere® resources that include medical and clinical information, convenient online ordering, and innovative digital resources.

“The new website highlights the resources and programs that make TheraSphere® a truly unique treatment offering,” said Steve West, Nordion CEO and Chief Operating Officer, Targeted Therapies. “With physicians and patients increasingly seeking digital delivery of treatment information and resources, the new TheraSphere.com website is the global hub that connects our users to a complete suite of training and support, whether they’re administrating their first TheraSphere® dose or their 100th.”

Specifically for physicians, the site offers convenient online access to a suite of unique TheraSphere® resources, including:

  • TheraSphere® Preceptor Program: Connects physicians with experienced interventional radiologists that provide medical and technical advice to treatment users.
  • TheraSphere® Resource Center iPad App: A comprehensive educational tool designed for healthcare professionals, placing valuable product information at their fingertips.
  • Online Ordering for Standard and Custom Doses: TheraSphere® users can order product online or by email, phone or fax. This includes custom doses, which are designed to provide greater treatment flexibility for physicians, save administration time and reduce product waste.
  • Expanded clinical trial information: Up-to-date information on TheraSphere® Phase III clinical trials, which include YES-P (liver cancer patients with portal vein thrombosis) STOP-HCC (patients with hepatocellular carcinoma) and EPOCH (patients with colorectal cancer whose disease has metastasized to the liver).

In addition to the TheraSphere® animation video and comprehensive Patient Information Guide, liver cancer patients and caregivers around the world can now find product information in their language, on dedicated pages offering quick access to treatment centers and resources specific to their location.

The new TheraSphere.com website is optimized for mobile devices and all modern browsers, to meet the needs of users on the go, on their platform of choice.

Visitors can also follow @NordionInc on Twitter to keep up-to-date on TheraSphere® news and upcoming events, and can subscribe to the Nordion YouTube channel for the latest video content.

To learn more, visit the Nordion booth at the following interventional oncology industry events:

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,882.12 -103.49 -0.61%
S&P 500 1,963.18 -9.65 -0.49%
NASDAQ 4,392.6720 -26.3620 -0.60%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs